Draegerwerk AG KGaA (Draegerwerk AG KGaA) 3-Year EBITDA Growth Rate : -24.90% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Draegerwerk AG KGaA 3-Year EBITDA Growth Rate?

Draegerwerk AG KGaA's EBITDA per Share for the three months ended in Mar. 2024 was $0.92.

During the past 3 years, the average EBITDA Per Share Growth Rate was -24.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Draegerwerk AG KGaA was 57.80% per year. The lowest was -34.20% per year. And the median was -2.90% per year.

Competitive Comparison of Draegerwerk AG KGaA's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Draegerwerk AG KGaA's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Draegerwerk AG KGaA's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Draegerwerk AG KGaA's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Draegerwerk AG KGaA's 3-Year EBITDA Growth Rate falls into.

Draegerwerk AG KGaA 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Draegerwerk AG KGaA (OTCPK:DGWPF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Draegerwerk AG KGaA 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Draegerwerk AG KGaA's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Draegerwerk AG KGaA (Draegerwerk AG KGaA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Draegerwerk AG & Co KGaA (OTCPK:DGWPF) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

0K5E:UK DRW3:Germany DRW3:Austria

Address

Moislinger Allee 53–55, Lubeck, DEU, 23542

Website

https://www.draeger.com

Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two divisions: medical and safety. The medical division contributes the majority of revenue. The company develops and produce system solutions, equipment, and services for the acute point of care. The five business units are Therapy (anesthesia devices and ventilators, as well as thermoregulation equipment), Hospital Consumables & Accessories (consumables and accessories), Workplace Infrastructure (supply units, lights, gas management systems), Monitoring (patient monitoring), and Data Business (software applications, system products, and new services). Draegerwerk's geographical segments are Europe; Americas; and Africa, Asia, and Australia.

Draegerwerk AG KGaA (Draegerwerk AG KGaA) Headlines

From GuruFocus

Dr�ger receives Frost & Sullivan's 2024 Best Practices Company of the Year Award in global respiratory care

By PRNewswire • 02-29-2024